CIK 0001369568
CPRX CATALYST PHARMACEUTICALS, INC.
Insider trading from SEC Form 4. Last filing Dec 31, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Signals
Open-market buys and sells at CATALYST PHARMACEUTICALS, INC., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 40Moderate | sell 4 | Miller Steve Chief Op. & Scientific Officer | $1.1M | 50,000 | -7% | - | |
| 29Weak | sell 5 | Elsbernd Brian Chief Compliance/Legal Officer | $287k | 13,256 | -8% | - | |
| 51Moderate | sell 5 | Harper Molly director | $385k | 17,500 | -100% | - | |
| 33Weak | sell 5 | INGENITO GARY Chief Med. & Reg. Officer | $273k | 12,000 | -19% | - | |
| 47Moderate | sell 4 | INGENITO GARY Chief Med. & Reg. Officer | $806k | 38,000 | -43% | - | |
| 40Moderate | sell 4 | MCENANY PATRICK J director, other | $3.6M | 170,845 | -4% | - | |
| 40Moderate | sell 4 | MCENANY PATRICK J director, other | $3.1M | 137,155 | -3% | - | |
| 38Weak | sell 2 | MCENANY PATRICK J director, other | $12M | 492,000 | -10% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Common stock, par value $0.001 per share | +14,000 | - | - | 935,996 | Dec 31, 2024 |
| Dec 27, 2024 | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Common stock, par value $0.001 per share | +8,667 | - | - | 26,720 | Dec 31, 2024 |
| Dec 27, 2024 | DENKHAUS DONALD A director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 441,079 | Dec 31, 2024 |
| Dec 27, 2024 | Harper Molly director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 2,746 | Dec 31, 2024 |
| Dec 27, 2024 | O'Keeffe Charles B director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 728,470 | Dec 31, 2024 |
| Dec 27, 2024 | Sundaram Preethi Chief Strategy Officer | MOption exercise Common Stock, par value $0.001 per share | +6,667 | - | - | 36,648 | Dec 31, 2024 |
| Dec 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Common Stock, par value $0.001 per share | +9,000 | - | - | 64,849 | Dec 31, 2024 |
| Dec 27, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Common Stock, par value $0.001 per share | +6,667 | - | - | 183,191 | Dec 31, 2024 |
| Dec 27, 2024 | Tierney David S director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 351,620 | Dec 31, 2024 |
| Dec 27, 2024 | Daly Richard J President and CEO | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 236,157 | Dec 31, 2024 |
| Dec 27, 2024 | DENKHAUS DONALD A director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | O'Keeffe Charles B director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | Del Carmen Jeffrey Chief Commercial Officer | FTax withholding Common stock, par value $0.001 per share | -3,839 | - | - | 22,881 | Dec 31, 2024 |
| Dec 27, 2024 | Sundaram Preethi Chief Strategy Officer | FTax withholding Common Stock, par value $0.001 per share | -2,345 | - | - | 34,303 | Dec 31, 2024 |
| Dec 27, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Restricted Stock Unitsderivative | -14,000 | $0.00 | $0 | 1,538,176 | Dec 31, 2024 |
| Dec 27, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | FTax withholding Common Stock, par value $0.001 per share | -1,941 | - | - | 181,250 | Dec 31, 2024 |
| Dec 27, 2024 | Tierney David S director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | FTax withholding Common Stock, par value $0.001 per share | -3,541 | - | - | 61,308 | Dec 31, 2024 |
| Dec 27, 2024 | Daly Richard J President and CEO | FTax withholding Common Stock, par value $0.001 per share | -324 | - | - | 235,833 | Dec 31, 2024 |
| Dec 27, 2024 | Harper Molly director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 131,274 | Dec 31, 2024 |
| Dec 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Restricted Stock Unitsderivative | -9,000 | $0.00 | $0 | 1,025,282 | Dec 31, 2024 |
| Dec 27, 2024 | Sundaram Preethi Chief Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -6,667 | $0.00 | $0 | 695,099 | Dec 31, 2024 |
| Dec 27, 2024 | Daly Richard J President and CEO | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 2,280,858 | Dec 31, 2024 |
| Dec 27, 2024 | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -8,667 | $0.00 | $0 | 941,675 | Dec 31, 2024 |
| Dec 27, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Restricted Stock Unitsderivative | -6,667 | $0.00 | $0 | 1,081,276 | Dec 31, 2024 |
| Dec 13, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Common stock, par value $0.001 per share | +235,000 | $4.01 | $942k | 921,996 | Dec 17, 2024 |
| Dec 13, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Options to purchase common stockderivative | -235,000 | $0.00 | $0 | 1,552,176 | Dec 17, 2024 |
| Dec 9, 2024 | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Common stock, par value $0.001 per share | +8,039 | - | - | 20,408 | Dec 11, 2024 |
| Dec 9, 2024 | DENKHAUS DONALD A director | MOption exercise Common Stock, par value $0.001 per share | +1,413 | - | - | 439,746 | Dec 11, 2024 |
| Dec 9, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Common Stock, par value $0.001 per share | +7,067 | - | - | 178,244 | Dec 11, 2024 |
| Dec 9, 2024 | Harper Molly director | MOption exercise Common Stock, par value $0.001 per share | +1,413 | - | - | 1,413 | Dec 11, 2024 |
| Dec 9, 2024 | Tierney David S director | MOption exercise Common Stock, par value $0.001 per share | +1,413 | - | - | 350,287 | Dec 11, 2024 |
| Dec 9, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Common Stock, par value $0.001 per share | +7,349 | - | - | 58,740 | Dec 11, 2024 |
| Dec 9, 2024 | MCENANY PATRICK J director, other | MOption exercise Common Stock, par value $0.001 per share | +3,533 | - | - | 4,481,702 | Dec 11, 2024 |
| Dec 9, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Common stock, par value $0.001 per share | +11,872 | - | - | 686,996 | Dec 11, 2024 |
| Dec 9, 2024 | O'Keeffe Charles B director | MOption exercise Common Stock, par value $0.001 per share | +1,413 | - | - | 687,137 | Dec 11, 2024 |
| Dec 9, 2024 | Sundaram Preethi Chief Strategy Officer | MOption exercise Common Stock, par value $0.001 per share | +6,855 | - | - | 32,396 | Dec 11, 2024 |
| Dec 9, 2024 | Thompson Tamar director | MOption exercise Common Stock, par value $0.001 per share | +1,413 | - | - | 1,413 | Dec 11, 2024 |
| Dec 9, 2024 | Del Carmen Jeffrey Chief Commercial Officer | FTax withholding Common stock, par value $0.001 per share | -2,355 | - | - | 18,053 | Dec 11, 2024 |
| Dec 9, 2024 | INGENITO GARY Chief Med. & Reg. Officer | FTax withholding Common Stock, par value $0.001 per share | -2,891 | - | - | 55,849 | Dec 11, 2024 |
| Dec 9, 2024 | DENKHAUS DONALD A director | MOption exercise Restricted Stock Unitsderivative | -1,413 | $0.00 | $0 | 213,607 | Dec 11, 2024 |
| Dec 9, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | FTax withholding Common Stock, par value $0.001 per share | -1,720 | - | - | 176,524 | Dec 11, 2024 |
| Dec 9, 2024 | Harper Molly director | MOption exercise Restricted Stock Unitsderivative | -1,413 | $0.00 | $0 | 132,607 | Dec 11, 2024 |
| Dec 9, 2024 | MCENANY PATRICK J director, other | MOption exercise Restricted Stock Unitsderivative | -3,533 | $0.00 | $0 | 1,838,130 | Dec 11, 2024 |
| Dec 10, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Common stock, par value $0.001 per share | +50,000 | $4.01 | $201k | 736,996 | Dec 11, 2024 |
| Dec 9, 2024 | Sundaram Preethi Chief Strategy Officer | FTax withholding Common Stock, par value $0.001 per share | -2,415 | - | - | 29,981 | Dec 11, 2024 |
| Dec 9, 2024 | Thompson Tamar director | MOption exercise Restricted Stock Unitsderivative | -1,413 | $0.00 | $0 | 98,440 | Dec 11, 2024 |
| Dec 9, 2024 | Tierney David S director | MOption exercise Restricted Stock Unitsderivative | -1,413 | $0.00 | $0 | 213,607 | Dec 11, 2024 |
| Dec 10, 2024 | O'Keeffe Charles B director | MOption exercise Common Stock, par value $0.001 per share | +40,000 | $4.01 | $160k | 727,137 | Dec 11, 2024 |
| Dec 9, 2024 | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -8,039 | $0.00 | $0 | 950,342 | Dec 11, 2024 |
| Dec 9, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Restricted Stock Unitsderivative | -7,067 | $0.00 | $0 | 1,087,943 | Dec 11, 2024 |
| Dec 9, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Restricted Stock Unitsderivative | -7,349 | $0.00 | $0 | 1,034,282 | Dec 11, 2024 |
| Dec 9, 2024 | O'Keeffe Charles B director | MOption exercise Restricted Stock Unitsderivative | -1,413 | $0.00 | $0 | 253,607 | Dec 11, 2024 |
| Dec 9, 2024 | Sundaram Preethi Chief Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -6,855 | $0.00 | $0 | 701,766 | Dec 11, 2024 |
| Dec 10, 2024 | Miller Steve Chief Op. & Scientific Officer | SOpen-market sale Common stock, par value $0.001 per share | -50,000 | $21.93 | $1.1M | 686,996 | Dec 11, 2024 |
| Dec 10, 2024 | O'Keeffe Charles B director | MOption exercise Options to purchase common stockderivative | -40,000 | $0.00 | $0 | 213,607 | Dec 11, 2024 |
| Dec 9, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Restricted Stock Unitsderivative | -11,872 | $0.00 | $0 | 1,837,176 | Dec 11, 2024 |
| Dec 10, 2024 | Miller Steve Chief Op. & Scientific Officer | MOption exercise Options to purchase common stockderivative | -50,000 | $0.00 | $0 | 1,787,176 | Dec 11, 2024 |
| Nov 26, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Common Stock, par value $0.001 per share | +50,244 | $4.01 | $201k | 174,677 | Nov 29, 2024 |
| Nov 27, 2024 | Harper Molly director | MOption exercise Common stock, par value $0.001 per share | +17,500 | $5.78 | $101k | 17,500 | Nov 29, 2024 |
| Nov 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Common stock, par value $0.001 per share | +12,000 | $4.01 | $48k | 63,391 | Nov 29, 2024 |
| Nov 26, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | SOpen-market sale Common Stock, par value $0.001 per share | -9,300 | $21.65 | $201k | 165,377 | Nov 29, 2024 |
| Nov 27, 2024 | Harper Molly director | SOpen-market sale Common stock, par value $0.001 per share | -17,500 | $22.00 | $385k | 0 | Nov 29, 2024 |
| Nov 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | SOpen-market sale Common stock, par value $0.001 per share | -8,631 | $22.74 | $196k | 54,760 | Nov 29, 2024 |
| Nov 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | SOpen-market sale Common stock, par value $0.001 per share | -3,369 | $22.67 | $76k | 51,391 | Nov 29, 2024 |
| Nov 26, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Common Stock, par value $0.001 per share | +9,756 | $4.01 | $39k | 175,133 | Nov 29, 2024 |
| Nov 27, 2024 | Harper Molly director | MOption exercise Options to purchase common stockderivative | -17,500 | $0.00 | $0 | 134,020 | Nov 29, 2024 |
| Nov 27, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Options to purchase common stockderivative | -12,000 | $0.00 | $0 | 1,041,631 | Nov 29, 2024 |
| Nov 26, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | SOpen-market sale Common Stock, par value $0.001 per share | -3,956 | $21.58 | $85k | 171,177 | Nov 29, 2024 |
| Nov 26, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Options to Purchase Common Stockderivative | -50,244 | $0.00 | $0 | 1,104,766 | Nov 29, 2024 |
| Nov 26, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Options to Purchase Common Stockderivative | -9,756 | $0.00 | $0 | 1,095,010 | Nov 29, 2024 |
| Nov 21, 2024 | Daly Richard J President and CEO | AGrant or award Options to purchase common stockderivative | +491,160 | $0.00 | $0 | 2,222,172 | Nov 25, 2024 |
| Nov 21, 2024 | Del Carmen Jeffrey Chief Commercial Officer | AGrant or award Options to purchase common stockderivative | -137,553 | $0.00 | $0 | 941,572 | Nov 25, 2024 |
| Nov 21, 2024 | DENKHAUS DONALD A director | AGrant or award Options to purchase common stockderivative | +23,248 | $0.00 | $0 | 212,179 | Nov 25, 2024 |
| Nov 21, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | AGrant or award Options to purchase common stockderivative | +126,704 | $0.00 | $0 | 1,139,527 | Nov 25, 2024 |
| Nov 21, 2024 | Harper Molly director | AGrant or award Options to purchase common stockderivative | +23,248 | $0.00 | $0 | 148,679 | Nov 25, 2024 |
| Nov 21, 2024 | INGENITO GARY Chief Med. & Reg. Officer | AGrant or award Options to purchase common stockderivative | +125,696 | $0.00 | $0 | 1,038,271 | Nov 25, 2024 |
| Nov 21, 2024 | Kalb Michael Wayne Executive Vice President & CFO | AGrant or award Options to purchase common stockderivative | +169,248 | $0.00 | $0 | 462,155 | Nov 25, 2024 |
| Nov 21, 2024 | MCENANY PATRICK J director, other | AGrant or award Options to purchase common stockderivative | +43,591 | $0.00 | $0 | 1,836,336 | Nov 25, 2024 |
| Nov 21, 2024 | Miller Steve Chief Op. & Scientific Officer | AGrant or award Options to purchase common stockderivative | +202,958 | $0.00 | $0 | 1,824,247 | Nov 25, 2024 |
| Nov 21, 2024 | O'Keeffe Charles B director | AGrant or award Options to purchase common stockderivative | +23,248 | $0.00 | $0 | 252,179 | Nov 25, 2024 |
| Nov 21, 2024 | Sundaram Preethi Chief Strategy Officer | AGrant or award Options to purchase common stockderivative | +137,553 | $0.00 | $0 | 691,812 | Nov 25, 2024 |
| Nov 21, 2024 | Thompson Tamar director | AGrant or award Options to purchase common stockderivative | +23,248 | $0.00 | $0 | 97,012 | Nov 25, 2024 |
| Nov 21, 2024 | Tierney David S director | AGrant or award Options to purchase common stockderivative | +23,248 | $0.00 | $0 | 212,179 | Nov 25, 2024 |
| Nov 21, 2024 | Daly Richard J President and CEO | AGrant or award Restricted Stock Unitsderivative | +60,019 | $0.00 | $0 | 2,282,191 | Nov 25, 2024 |
| Nov 21, 2024 | Del Carmen Jeffrey Chief Commercial Officer | AGrant or award Restricted Stock Unitsderivative | -16,809 | $0.00 | $0 | 958,381 | Nov 25, 2024 |
| Nov 21, 2024 | DENKHAUS DONALD A director | AGrant or award Restricted Stock Unitsderivative | +2,841 | $0.00 | $0 | 215,020 | Nov 25, 2024 |
| Nov 21, 2024 | Elsbernd Brian Chief Compliance/Legal Officer | AGrant or award Restricted Stock Unitsderivative | +15,483 | $0.00 | $0 | 1,155,010 | Nov 25, 2024 |
| Nov 21, 2024 | Harper Molly director | AGrant or award Restricted Stock Unitsderivative | +2,841 | $0.00 | $0 | 151,520 | Nov 25, 2024 |
| Nov 21, 2024 | INGENITO GARY Chief Med. & Reg. Officer | AGrant or award Restricted Stock Unitsderivative | +15,360 | $0.00 | $0 | 1,053,631 | Nov 25, 2024 |
| Nov 21, 2024 | Kalb Michael Wayne Executive Vice President & CFO | AGrant or award Restricted Stock Unitsderivative | +20,682 | $0.00 | $0 | 482,837 | Nov 25, 2024 |
| Nov 21, 2024 | MCENANY PATRICK J director, other | AGrant or award Restricted Stock Unitsderivative | +5,327 | $0.00 | $0 | 1,841,663 | Nov 25, 2024 |
| Nov 21, 2024 | Miller Steve Chief Op. & Scientific Officer | AGrant or award Restricted Stock Unitsderivative | +24,801 | $0.00 | $0 | 1,849,048 | Nov 25, 2024 |
| Nov 21, 2024 | O'Keeffe Charles B director | AGrant or award Restricted stock unitsderivative | +2,841 | $0.00 | $0 | 255,020 | Nov 25, 2024 |
| Nov 21, 2024 | Sundaram Preethi Chief Strategy Officer | AGrant or award Options to purchase common stockderivative | +16,809 | $0.00 | $0 | 708,621 | Nov 25, 2024 |
| Nov 21, 2024 | Thompson Tamar director | AGrant or award Restricted Stock Unitsderivative | +2,841 | $0.00 | $0 | 99,853 | Nov 25, 2024 |
| Nov 21, 2024 | Tierney David S director | AGrant or award Restricted Stock Unitsderivative | +2,841 | $0.00 | $0 | 215,020 | Nov 25, 2024 |
| Nov 20, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Common stock, par value $0.001 per share | +38,000 | $4.01 | $152k | 89,391 | Nov 22, 2024 |
| Nov 20, 2024 | INGENITO GARY Chief Med. & Reg. Officer | SOpen-market sale Common stock, par value $0.001 per share | -38,000 | $21.20 | $806k | 51,391 | Nov 22, 2024 |
| Nov 20, 2024 | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Options to purchase common stockderivative | -38,000 | $0.00 | $0 | 912,575 | Nov 22, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- DENKHAUS DONALD Adirector
- Daly Richard JPresident and CEO
- Del Carmen JeffreyChief Commercial Officer
- Elsbernd BrianChief Compliance/Legal Officer
- Harper Mollydirector
- INGENITO GARYChief Med. & Reg. Officer
- Kalb Michael WayneExecutive Vice President & CFO
- MCENANY PATRICK Jdirector, other
- Miller SteveChief Op. & Scientific Officer
- O'Keeffe Charles Bdirector
- Sundaram PreethiChief Strategy Officer
- Thompson Tamardirector
- Tierney David Sdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.